Skin + Me is a UK-based startup that provides personalized, prescription-based skincare solutions to address the problem of finding affordable, quality skincare products. Recently, the company secured £10M in Series B funding led by Octopus Ventures. Skin + Me aims to revolutionize the skincare industry by making medical-grade advice more accessible and boosting skin confidence through personalized skincare solutions.
Skin + Me recently secured £10M in Series B funding led by Octopus Ventures. The company’s success is driven by increasing consumer awareness of prescription ingredients and a growing trend towards personalization in the skincare industry. Horatio Cary, Co-Founder and CEO of Skin + Me, stated that the global skincare industry is worth £140bn, and Skin + Me is ideally placed as the market leader in the UK to take advantage of the trend towards prescription-strength ingredients.
Will Gibbs, Partner, Health, Octopus Ventures, added that Skin + Me has demonstrated their faith in the brand’s market-leading personalization strategy, which reflects the step change in the skincare market. Octopus Ventures has invested a total of £13m across Series A and Series B funding to develop Skin + Me and deepen the relationship with the brand.
Skin + Me’s personalized, prescription-based approach to skincare seeks to address the negative impact on self-esteem and confidence caused by struggling with skincare. The company’s success is attributed to their delivery of medical skincare that is proven to be more effective than any cosmetic products through decades of clinical studies. Skin + Me’s approach is aligned with the increasing consumer demand for prescription-only ingredients, such as tretinoin, and a growing trend towards personalization in the skincare industry.
In conclusion, Skin + Me’s recent fundraising success reflects the growing trend towards personalized, prescription-based skincare solutions that are proven to be more effective than cosmetic products. Skin + Me’s approach to skincare is aligned with the increasing consumer demand for prescription-strength ingredients and the trend towards personalization in the skincare industry.
